##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H173-301222-ROCHE_S121_R
1	2558346	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=1642;GeneNames=TNFRSF14;GeneIDs=8764;Aliases=ATAR,CD270,HVEA,HVEM,LIGHTR,TR2;Genes=1;TranscriptNameClinicallyRelevant=NM_003820.4;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000001.11:g.2558346_2559987dup;HGVScClinicallyRelevant=NM_003820.4:c.182_460+9dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p36.32;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=2559987	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:149.476:3.98257:1.4121:1.03632338813015e-05:TNFRSF14::TNFRSF14:NM_003820.4:VUS:2L0ThiscnvpartiallyoverlapstheTNFRSF14genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	12793226	.	N	<DUP>	.	.	Type=Gain;Targets=17;Samples2=1;Span=99993;GeneNames=HNRNPCL1,LINC01784,PRAMEF1,PRAMEF2,PRAMEF4,PRAMEF10,PRAMEF11;GeneIDs=65121,105376745,440560,343069,65122,400735,343071;Genes=7;TranscriptNameClinicallyRelevant=NM_001013631.3,NR_146629.1,NM_023013.4,NM_023014.1,NM_001009611.4,NM_001039361.4,NM_001146344.3;OverlappingExonsClinicallyRelevant=All,All,2-4,All,All,4,All;HGVSg=NC_000001.11:g.12793226_12893218dup;HGVScClinicallyRelevant=.,.,.,.,.,NM_001039361.4:c.1425_*1ins(303),.;HGVSpClinicallyRelevant=.,.,.,.,.,NP_001034450.3:p.476Hext*101,.;ISCNCytobandNotation=dup(1)p36.21;SequenceOntologyClinicallyRelevant=.,.,.,.,.,stop_lost,.;RegionClinicallyRelevant=.,.,.,.,.,exon,.;Region=1:12771339-13127228,1:12774773-12911690,1:12778601-12992795,1:12779834-12859897,1:12785720-12832166,1:12806942-12860808,1:12831630-12893635,1:12833755-12866523,1:12848985-12889447;Span2=355890,136918,214195,80064,46447,53867,62006,32769,40463;OverlapType=Within Region,Within Region,Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Contains Region,Contains Region;Name=gssvG344,gssvG349,gssvG347,gssvG354,gssvG368,gssvG362,gssvG359,gssvG371,gssvG369;Frequency=0.0008,0.0267,0.0029,0.0058,0.0061,0.0003,0.194,0.1598,0.129;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=1:12786363-12982850,1:12835724-12872849;Span3=196488,37126;OverlapType2=Within Region,Contains Region;Type3=Duplication,Duplication;Frequency2=0.625,0.2;DeletionFrequency=0,0;DuplicationFrequency=0.625,0.2;END=12893218	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:317.377:2.02502:1.34643:5.89392304031823e-11:HNRNPCL1,LINC01784,PRAMEF1,PRAMEF2,PRAMEF4,PRAMEF10,PRAMEF11::HNRNPCL1:NM_001013631.3:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46308inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps6proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	25284564	.	N	<DEL>	.	.	Type=Loss;Targets=10;Samples2=9;Span=44581;GeneNames=RHD,RSRP1;GeneIDs=57035,6007;Aliases=C1orf63,NPD014;Genes=2;TranscriptNameClinicallyRelevant=NM_016124.6,NM_001321772.2;OverlappingExonsClinicallyRelevant=2-10,.;HGVSg=NC_000001.11:g.25284564_25329144del;HGVScClinicallyRelevant=NM_016124.6:c.149-9_1254del,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(1)p36.11;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=1:25247031-25367695,1:25258853-25313871,1:25266637-25338175,1:25301582-25338308;Span2=120665,55019,71539,36727;OverlapType=Within Region,Partial Overlap,Within Region,Partial Overlap;Name=gssvL1588,gssvL1591,gssvL1590,gssvL1592;Frequency=0.1525,0.014,0.0084,0.0149;Type2=Loss,Loss,Loss,Loss;Region2=1:25266921-25336019;Span3=69099;OverlapType2=Within Region;Type3=Deletion;Frequency2=0.436047;DeletionFrequency=0.436047;DuplicationFrequency=0;END=25329144	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-2.52153:0:3.5507567392545e-10:RHD,RSRP1::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:0
1	29195918	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=370;GeneNames=MECR;GeneIDs=51102;Aliases=CGI-63,DYTOABG,ETR1,FASN2B,NRBF1;Genes=1;TranscriptNameClinicallyRelevant=NM_016011.5;OverlappingExonsClinicallyRelevant=8-9;HGVSg=NC_000001.11:g.29195918_29196287dup;HGVScClinicallyRelevant=NM_016011.5:c.831-29_964+23dup;HGVSpClinicallyRelevant=NP_057095.4:p.D322Gfs*7;ISCNCytobandNotation=dup(1)p35.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=29196287	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:120.125:4.15514:1.42076:4.17594353247163e-06:MECR::MECR:NM_016011.5:VUS:2L0ThiscnvpartiallyoverlapstheMECRgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	31668768	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=6316;GeneNames=COL16A1;GeneIDs=1307;Aliases=447AA,FP1572;Genes=1;TranscriptNameClinicallyRelevant=NM_001856.4;OverlappingExonsClinicallyRelevant=44-50;HGVSg=NC_000001.11:g.31668768_31675083dup;HGVScClinicallyRelevant=NM_001856.4:c.2827-44_3249+34dup;HGVSpClinicallyRelevant=NP_001847.3:p.S944_G1084dup;ISCNCytobandNotation=dup(1)p35.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=31675083	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:117.074:2.73573:1.30609:1.66465474282871e-06:COL16A1:COL16A1:COL16A1:NM_001856.4:VUS:3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	36466348	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=982;GeneNames=CSF3R;GeneIDs=1441;Aliases=CD114,GCSFR,SCN7;Genes=1;TranscriptNameClinicallyRelevant=NM_000760.4;OverlappingExonsClinicallyRelevant=16-17;HGVSg=NC_000001.11:g.36466348_36467329dup;HGVScClinicallyRelevant=NM_000760.4:c.1959-18_2511dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p34.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=36467329	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:156.759:4.0963:1.38847:5.71554392693895e-06:CSF3R::CSF3R:NM_000760.4:VUS:2L0ThiscnvpartiallyoverlapstheCSF3Rgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	46572055	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=2;Span=37675;GeneNames=MKNK1,MOB3C;GeneIDs=8569,148932;Aliases=MNK1;Genes=2;TranscriptNameClinicallyRelevant=NM_001135553.4,NM_201403.3;OverlappingExonsClinicallyRelevant=1-7,4;HGVSg=NC_000001.11:g.46572055_46609729dup;HGVScClinicallyRelevant=NM_001135553.4:c.1_457+8dup,NM_201403.3:c.622-45_651dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(1)p33;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=46609729	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:103.135:2.43349:1.33855:4.58679053541782e-07:MKNK1,MOB3C::MKNK1:NM_001135553.4:VUS:2L0ThiscnvpartiallyoverlapstheMKNK1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	85842034	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=5744;GeneNames=COL24A1;GeneIDs=255631;Genes=1;TranscriptNameClinicallyRelevant=NM_152890.7;OverlappingExonsClinicallyRelevant=39-41;HGVSg=NC_000001.11:g.85842034_85847777dup;HGVScClinicallyRelevant=NM_152890.7:c.3355-5_3570+34dup;HGVSpClinicallyRelevant=NP_690850.2:p.D1120_G1191dup;ISCNCytobandNotation=dup(1)p22.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=85847777	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:91.5194:3.22344:1.39304:1.24431644358988e-05:COL24A1::COL24A1:NM_152890.7:VUS:2L0ThiscnvpartiallyoverlapstheCOL24A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	85877089	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=COL24A1;GeneIDs=255631;Genes=1;TranscriptNameClinicallyRelevant=NM_152890.7;OverlappingExonsClinicallyRelevant=33;HGVSg=NC_000001.11:g.85877089_85877208dup;HGVScClinicallyRelevant=NM_152890.7:c.2977-33_3030+33dup;HGVSpClinicallyRelevant=NP_690850.2:p.L994_G1011dup;ISCNCytobandNotation=dup(1)p22.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=85877208	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:81.075:5.09292:1.84602:6.77732558381281e-05:COL24A1::COL24A1:NM_152890.7:VUS:2L0ThiscnvpartiallyoverlapstheCOL24A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	102970186	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=COL11A1;GeneIDs=1301;Aliases=CO11A1,COLL6,DFNA37,STL2;Genes=1;TranscriptNameClinicallyRelevant=NM_001854.4;OverlappingExonsClinicallyRelevant=37;HGVSg=NC_000001.11:g.102970186_102970305dup;HGVScClinicallyRelevant=NM_001854.4:c.2809-33_2862+33dup;HGVSpClinicallyRelevant=NP_001845.3:p.P938_G955dup;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=102970305	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:75.275:4.99634:1.72598:9.32647209517428e-05:COL11A1::COL11A1:NM_001854.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL11A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	196774873	.	N	<DUP>	.	.	Type=Gain;Targets=26;Samples2=2;Span=143595;GeneNames=CFHR1,CFHR3,CFHR4;GeneIDs=10878,3078,10877;Aliases=CFHL3,DOWN16,FHR-3,FHR3,HLF4;Genes=3;TranscriptNameClinicallyRelevant=NM_002113.3,NM_021023.6,NM_001201550.3;OverlappingExonsClinicallyRelevant=All,All,All;HGVSg=NC_000001.11:g.196774873_196918467dup;HGVScClinicallyRelevant=.,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(1)q31.3;SequenceOntologyClinicallyRelevant=.,.,.;RegionClinicallyRelevant=.,.,.;Region=1:196710325-196866368,1:196741937-196947657,1:196778768-196847588,1:196801553-196844140,1:196812967-196954738,1:196814484-196862182,1:196850486-196913266;Span2=156044,205721,68821,42588,141772,47699,62781;OverlapType=Partial Overlap,Within Region,Contains Region,Contains Region,Partial Overlap,Contains Region,Contains Region;Name=gssvG2956,gssvG2955,gssvG2959,gssvG2966,gssvG2957,gssvG2964,gssvG2962;Frequency=0.0523,0.0021,0.0062,0.0011,0.0039,0.0017,0.0014;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain;END=196918467	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:169.542:2.04639:1.47941:2.68248993437252e-16:CFHR1,CFHR3,CFHR4::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps3proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	207564026	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=2;Span=4105;GeneNames=CR1;GeneIDs=1378;Aliases=C3BR,C4BR,CD35,KN;Genes=1;TranscriptNameClinicallyRelevant=NM_000651.6;OverlappingExonsClinicallyRelevant=22-25;HGVSg=NC_000001.11:g.207564026_207568130del;HGVScClinicallyRelevant=NM_000651.6:c.3749_4171+88del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(1)q32.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region2=1:207563806-207568041,1:207565908-207570644;Span3=4236,4737;OverlapType2=Partial Overlap,Partial Overlap;Type3=Deletion,Deletion;Frequency2=0.1,0.00118343;DeletionFrequency=0.1,0.00118343;DuplicationFrequency=0,0;END=207568130	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:71.9883:-2.97177:0.516968:3.06955847476539e-06:CR1::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
3	52528839	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=504;GeneNames=NT5DC2;GeneIDs=64943;Genes=1;TranscriptNameClinicallyRelevant=NM_001134231.2;OverlappingExonsClinicallyRelevant=2-3;HGVSg=NC_000003.12:g.52528839_52529342dup;HGVScClinicallyRelevant=NM_001134231.2:c.233-8_492+22dup;HGVSpClinicallyRelevant=NP_001127703.1:p.S165Tfs*11;ISCNCytobandNotation=dup(3)p21.1;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=52529342	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:168.276:3.98008:1.41413:1.04969951347624e-05:NT5DC2::NT5DC2:NM_001134231.2:VUS:2L0ThiscnvpartiallyoverlapstheNT5DC2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	58105088	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=1795;GeneNames=FLNB;GeneIDs=2317;Aliases=ABP-278,ABP-280,AOI,FH1,FLN-B,FLN1L,LRS1,TABP,TAP;Genes=1;TranscriptNameClinicallyRelevant=NM_001457.4;OverlappingExonsClinicallyRelevant=11-12;HGVSg=NC_000003.12:g.58105088_58106882dup;HGVScClinicallyRelevant=NM_001457.4:c.1619_1941+9dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(3)p14.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=58106882	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:173.244:3.65965:1.43237:5.16353018823077e-05:FLNB::FLNB:NM_001457.4:VUS:2L0ThiscnvpartiallyoverlapstheFLNBgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	114034915	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=CCDC191;GeneIDs=57577;Aliases=KIAA1407;Genes=1;TranscriptNameClinicallyRelevant=NM_020817.2;OverlappingExonsClinicallyRelevant=6;HGVSg=NC_000003.12:g.114034915_114035034dup;HGVScClinicallyRelevant=NM_020817.2:c.818+10_818+11ins(120);HGVSpClinicallyRelevant=NP_065868.1:p.?;ISCNCytobandNotation=dup(3)q13.31;SequenceOntologyClinicallyRelevant=splice_donor_variant;RegionClinicallyRelevant=exon;END=114035034	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:199.592:5.13617:1.57612:5.86411701326095e-05:CCDC191::CCDC191:NM_020817.2:VUS:2L0ThiscnvpartiallyoverlapstheCCDC191genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
6	32039346	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=868;GeneNames=CYP21A2;GeneIDs=1589;Aliases=CA21H,CAH1,CYP21,CYP21B,P450c21B;Genes=1;TranscriptNameClinicallyRelevant=NM_000500.9;OverlappingExonsClinicallyRelevant=4-7;HGVSg=NC_000006.12:g.32039346_32040213dup;HGVScClinicallyRelevant=NM_000500.9:c.448-10_939+8dup;HGVSpClinicallyRelevant=NP_000491.4:p.R150_E313dup;ISCNCytobandNotation=dup(6)p21.33;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=32040213	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:167.451:2.92737:1.37706:7.37551263904462e-05:CYP21A2::CYP21A2:NM_000500.9:Benign:2L0ThiscnvpartiallyoverlapstheCYP21A2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
7	31815914	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=250;GeneNames=PDE1C;GeneIDs=5137;Aliases=DFNA74,Hcam3,cam-PDE 1C,hCam-3;Genes=1;TranscriptNameClinicallyRelevant=NM_001191057.4;OverlappingExonsClinicallyRelevant=15;HGVSg=NC_000007.14:g.31815914_31816163dup;HGVScClinicallyRelevant=NM_001191057.4:c.1583-9_1813+10dup;HGVSpClinicallyRelevant=NP_001177986.1:p.E528_N604dup;ISCNCytobandNotation=dup(7)p14.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=31816163	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:163.35:4.34544:1.47644:1.47097788518381e-06:PDE1C::PDE1C:NM_001191057.4:VUS:2L0ThiscnvpartiallyoverlapsthePDE1Cgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	74782941	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=2;Span=15364;GeneNames=GTF2IRD2,NCF1;GeneIDs=653361,84163;Aliases=CGD1,NCF1A,NOXO2,SH3PXD1A,p47phox;Genes=2;TranscriptNameClinicallyRelevant=NM_173537.5,NM_000265.7;OverlappingExonsClinicallyRelevant=16,6-11;HGVSg=NC_000007.14:g.74782941_74798304dup;HGVScClinicallyRelevant=NM_173537.5:c.1247-39_2850dup,NM_000265.7:c.454_1173dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(7)q11.23;SequenceOntologyClinicallyRelevant=transcript_ablation,3_prime_UTR_variant;RegionClinicallyRelevant=exon,UTR3;END=74798304	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:99.0753:2.70468:1.35148:2.32304847649493e-05:GTF2IRD2,NCF1::GTF2IRD2:NM_173537.5:VUS:2L0ThiscnvpartiallyoverlapstheGTF2IRD2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	99052195	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=260;GeneNames=SMURF1;GeneIDs=57154;Genes=1;TranscriptNameClinicallyRelevant=NM_181349.3;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000007.14:g.99052195_99052454dup;HGVScClinicallyRelevant=NM_181349.3:c.480-8_721+10dup;HGVSpClinicallyRelevant=NP_851994.1:p.Q242Rfs*114;ISCNCytobandNotation=dup(7)q22.1;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=99052454	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:137.371:3.98981:1.4348:9.98235651898842e-06:SMURF1::SMURF1:NM_181349.3:VUS:2L0ThiscnvpartiallyoverlapstheSMURF1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
8	11996163	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=2;Span=142676;GeneNames=DEFB130B,DEFB134,FAM66D,LOC392196,USP17L2,USP17L7,ZNF705D;GeneIDs=613211,100133267,728957,100132923,392196,392197,377630;Genes=7;TranscriptNameClinicallyRelevant=NM_001195257.1,NM_001302695.2,NR_027425.1,NR_003275.2,NM_201402.3,NM_001256869.2,NM_001039615.3;OverlappingExonsClinicallyRelevant=All,1-2,1-2,All,All,All,All;HGVSg=NC_000008.11:g.11996163_12138838dup;HGVScClinicallyRelevant=.,NM_001302695.2:c.1_58+31dup,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.;ISCNCytobandNotation=dup(8)p23.1;SequenceOntologyClinicallyRelevant=.,transcript_ablation,.,.,.,.,.;RegionClinicallyRelevant=.,exon,.,.,.,.,.;Region=8:12003313-12202446,8:12005794-12034831,8:12044191-12145208,8:12077151-12204348;Span2=199134,29038,101018,127198;OverlapType=Partial Overlap,Contains Region,Partial Overlap,Partial Overlap;Name=gssvG36755,gssvG36781,gssvG36764,gssvG36761;Frequency=0.0146,0.0088,0.0017,0.0111;Type2=Gain,Gain,Gain,Gain;Region2=8:11809519-12114324,8:12042404-12082493;Span3=304806,40090;OverlapType2=Partial Overlap,Contains Region;Type3=Duplication,Duplication;Frequency2=0.00118343,0.025;DeletionFrequency=0,0;DuplicationFrequency=0.00118343,0.025;END=12138838	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:402.66:1.69286:1.72011:7.29595142908379e-05:DEFB130B,DEFB134,FAM66D,LOC392196,USP17L2,USP17L7,ZNF705D::DEFB134:NM_001302695.2:VUS:2L0ThiscnvpartiallyoverlapstheDEFB134genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps5proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
9	13115232	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=MPDZ;GeneIDs=8777;Aliases=HYC2,MUPP1;Genes=1;TranscriptNameClinicallyRelevant=NM_003829.5;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000009.12:g.13115232_13115351dup;HGVScClinicallyRelevant=NM_003829.5:c.5380-1211_5380-1210ins(120);HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(9)p23;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;END=13115351	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:238.892:6.22255:1.56209:1.0749631045825e-06:MPDZ::MPDZ:NM_003829.5:VUS:2L0ThiscnvpartiallyoverlapstheMPDZgenewhichhasunknownclinicalsignificance,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:3
9	39355671	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=3;Span=6207;GeneNames=SPATA31A1;GeneIDs=647060;Aliases=C9orf36,C9orf36A,FAM75A1,FAM75A2,SPATA31A2;Genes=1;TranscriptNameClinicallyRelevant=NM_001085452.4;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000009.12:g.39355671_39361877del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(9)p12;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=39361877	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:41.5767:-2.37004:0.537991:0.00020426746620064:SPATA31A1::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
12	27297728	.	N	<DUP>	.	.	Type=Gain;Targets=41;Samples2=1;Span=337453;GeneNames=ARNTL2,ARNTL2-AS1,PPFIBP1,SMCO2,STK38L;GeneIDs=23012,56938,101928646,341346,8496;Aliases=NDR2;Genes=5;TranscriptNameClinicallyRelevant=NM_020183.6,NR_109975.1,NM_003622.4,NM_001395208.2,NM_015000.4;OverlappingExonsClinicallyRelevant=All,All,1-4,All,2-14;HGVSg=NC_000012.12:g.27297728_27635180dup;HGVScClinicallyRelevant=.,.,NM_003622.4:c.1_270+65dup,.,NM_015000.4:c.8_1395dup;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(12)p11.23-p11.22;SequenceOntologyClinicallyRelevant=.,.,transcript_ablation,.,3_prime_UTR_variant;RegionClinicallyRelevant=.,.,exon,.,UTR3;Region=12:27128236-27640822;Span2=512587;OverlapType=Within Region;Name=gssvG7656;Frequency=0.0003;Type2=Gain;Region2=12:27130520-27640834;Span3=510315;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.000506842;DeletionFrequency=0;DuplicationFrequency=0.000506842;END=27635180	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:126.185:2.79714:1.29951:5.98456447276833e-45:ARNTL2,ARNTL2-AS1,PPFIBP1,SMCO2,STK38L::PPFIBP1:NM_003622.4:VUS:2L0ThiscnvpartiallyoverlapsthePPFIBP1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
15	43698021	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=1;Span=1070;GeneNames=CKMT1A;GeneIDs=548596;Aliases=CKMT1,U-MtCK,mia-CK;Genes=1;TranscriptNameClinicallyRelevant=NM_001321926.2;OverlappingExonsClinicallyRelevant=7-9;HGVSg=NC_000015.10:g.43698021_43699090del;HGVScClinicallyRelevant=NM_001321926.2:c.884_1254del;HGVSpClinicallyRelevant=NP_001308855.1:p.R295Text?;ISCNCytobandNotation=del(15)q15.3;SequenceOntologyClinicallyRelevant=stop_lost;RegionClinicallyRelevant=exon;Region2=15:43697553-43698823;Span3=1271;OverlapType2=Partial Overlap;Type3=Deletion;Frequency2=0.00118343;DeletionFrequency=0.00118343;DuplicationFrequency=0;END=43699090	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:43.3389:-3.58826:0.511136:1.06159681912248e-06:CKMT1A::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
16	22008295	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=8;Span=72594;GeneNames=MOSMO;GeneIDs=730094;Aliases=ATTHOG,BC030336,C16orf52;Genes=1;TranscriptNameClinicallyRelevant=NM_001164579.2;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000016.10:g.22008295_22080888dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p12.2;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=22080888	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:140.6:2.87227:1.44305:6.90860016943247e-06:MOSMO::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:3
16	24556318	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=3;Span=2220;GeneNames=RBBP6;GeneIDs=5930;Aliases=MY038,P2P-R,PACT,RBQ-1,SNAMA;Genes=1;TranscriptNameClinicallyRelevant=NM_006910.5;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000016.10:g.24556318_24558537dup;HGVScClinicallyRelevant=NM_006910.5:c.544_545ins(2220);HGVSpClinicallyRelevant=NP_008841.2:p.?;ISCNCytobandNotation=dup(16)p12.1;SequenceOntologyClinicallyRelevant=splice_donor_variant;RegionClinicallyRelevant=exon;END=24558537	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:72.1625:3.19811:1.43375:0.000414295855989367:RBBP6::RBBP6:NM_006910.5:VUS:2L0ThiscnvpartiallyoverlapstheRBBP6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	29876747	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=2;Span=1670;GeneNames=SEZ6L2;GeneIDs=26470;Aliases=BSRPA,PSK-1;Genes=1;TranscriptNameClinicallyRelevant=NM_201575.4;OverlappingExonsClinicallyRelevant=10-12;HGVSg=NC_000016.10:g.29876747_29878416dup;HGVScClinicallyRelevant=NM_201575.4:c.1583_2104+9dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p11.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=29878416	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:115.912:3.31202:1.38975:7.08869731326731e-06:SEZ6L2::SEZ6L2:NM_201575.4:VUS:2B0WhiletheCNVoverlapstheSEZ6L2geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37400inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheSEZ6L2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	17332920	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=8;Span=6689;GeneNames=ANO8,GTPBP3;GeneIDs=57719,84705;Aliases=KIAA1623,TMEM16H;Genes=2;TranscriptNameClinicallyRelevant=NM_020959.3,NM_133644.4;OverlappingExonsClinicallyRelevant=1-5,1-6;HGVSg=NC_000019.10:g.17332920_17339608dup;HGVScClinicallyRelevant=NM_020959.3:c.1_586+10dup,NM_133644.4:c.1_1070+9dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)p13.11;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;Region=19:17331902-17339470;Span2=7569;OverlapType=Partial Overlap;Name=gssvG18597;Frequency=0.0251;Type2=Gain;Region2=19:17331799-17339584,19:17332441-17339470,19:17332441-17339470,19:17335001-17337799,19:17337585-17339724;Span3=7786,7030,7030,2799,2140;OverlapType2=Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.0461538,0.025,0.0133333,0.00118343,0.00591716;DeletionFrequency=0,0,0,0,0;DuplicationFrequency=0.0461538,0.025,0.0133333,0.00118343,0.00591716;END=17339608	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:177.399:2.3198:1.26806:8.93418098718988e-09:ANO8,GTPBP3::ANO8:NM_020959.3:VUS:2L0ThiscnvpartiallyoverlapstheANO8genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	35153846	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=4586;GeneNames=FXYD5,FXYD7;GeneIDs=53822,53827;Genes=2;TranscriptNameClinicallyRelevant=NM_014164.6,NM_022006.2;OverlappingExonsClinicallyRelevant=1-4,6;HGVSg=NC_000019.10:g.35153846_35158431dup;HGVScClinicallyRelevant=NM_014164.6:c.1_199+31dup,NM_022006.2:c.221-48_243dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)q13.12;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=35158431	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:145.956:3.04061:1.32815:1.91118378077142e-06:FXYD5,FXYD7::FXYD5:NM_014164.6:VUS:2L0ThiscnvpartiallyoverlapstheFXYD5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	52841465	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=4;Span=12815;GeneNames=ZNF468;GeneIDs=90333;Genes=1;TranscriptNameClinicallyRelevant=NM_001008801.2;OverlappingExonsClinicallyRelevant=2-4;HGVSg=NC_000019.10:g.52841465_52854279dup;HGVScClinicallyRelevant=NM_001008801.2:c.1_829dup;HGVSpClinicallyRelevant=NP_001008801.1:p.G277Dfs*42;ISCNCytobandNotation=dup(19)q13.41;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;Region=19:52820494-52853920,19:52828661-52871577;Span2=33427,42917;OverlapType=Partial Overlap,Within Region;Name=gssvG19316,gssvG19312;Frequency=0.0066,0.0005;Type2=Gain,Gain;Region2=19:52819737-52858105,19:52819737-52858105;Span3=38369,38369;OverlapType2=Within Region,Within Region;Type3=Duplication,Duplication;Frequency2=0.025,0.953333;DeletionFrequency=0,0;DuplicationFrequency=0.025,0.953333;END=52854279	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:302.822:2.91063:1.31969:3.40791182738956e-07:ZNF468::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
22	19144513	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=4591;GeneNames=ESS2,GSC2;GeneIDs=8220,2928;Aliases=DGCR13,DGCR14,DGS-H,DGS-I,DGSH,DGSI,ES2,ESS-2,Es2el,bis1;Genes=2;TranscriptNameClinicallyRelevant=NM_022719.3,NM_005315.2;OverlappingExonsClinicallyRelevant=1,3;HGVSg=NC_000022.11:g.19144513_19149103dup;HGVScClinicallyRelevant=NM_022719.3:c.128_129ins(128),NM_005315.2:c.514-8_618dup;HGVSpClinicallyRelevant=NP_073210.1:p.Y43*,.;ISCNCytobandNotation=dup(22)q11.21;SequenceOntologyClinicallyRelevant=initiator_codon_variant,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=19149103	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:105.808:3.26984:1.46252:0.000304671007628398:ESS2,GSC2::ESS2:NM_022719.3:VUS:2B0WhiletheCNVoverlapstheESS2geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37433inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheESS2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
22	42130603	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=3;Span=12987;GeneNames=CYP2D6,CYP2D7;GeneIDs=1565,1564;Aliases=CPD6,CYP2D,CYP2D7AP,CYP2D7BP,CYP2D7P2,CYP2D8P2,CYP2DL1,CYPIID6,P450-DB1,P450C2D,P450DB1;Genes=2;TranscriptNameClinicallyRelevant=NM_000106.6,NR_145674.3;OverlappingExonsClinicallyRelevant=1,2-9;HGVSg=NC_000022.11:g.42130603_42143589dup;HGVScClinicallyRelevant=NM_000106.6:c.1_180+9dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(22)q13.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=22:42118886-42154516,22:42124870-42138033;Span2=35631,13164;OverlapType=Within Region,Partial Overlap;Name=gssvG24663,gssvG24665;Frequency=0.0142,0.2232;Type2=Gain,Gain;END=42143589	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:222.71:3.01995:1.31947:2.05665917764773e-11:CYP2D6,CYP2D7::CYP2D6:NM_000106.6:Benign:2L0ThiscnvpartiallyoverlapstheCYP2D6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
